197 related articles for article (PubMed ID: 15754508)
1. [Prevalence and course of fatigue in breast cancer: the kind of chemotherapy plays a role].
de Jong N; Candel M; Schouten H; Abu-Saad HH; Courtens A
Pflege Z; 2005 Feb; 58(2):100-3. PubMed ID: 15754508
[No Abstract] [Full Text] [Related]
2. [Fatigue in breast cancer patients with adjuvant chemotherapy: the 2nd day is the worst].
de Jong N; Courtens A; Abu-Saad HH; Schouten H
Pflege Z; 2003 Jan; 56(1):32-4. PubMed ID: 12630209
[No Abstract] [Full Text] [Related]
3. [Results of a study on fatigue in breast cancer patients receiving adjuvant chemotherapy: the first four days after treatment are the worst].
de Jong N; Kester AD; Schouten HC; Abu-Saad HH; Courtens AM
Pflege Z; 2007 Nov; 60(11):620-5. PubMed ID: 18062627
[TBL] [Abstract][Full Text] [Related]
4. Level of fatigue in women receiving dose-dense versus standard chemotherapy for breast cancer: a pilot study.
Sura W; Murphy SO; Gonzales I
Oncol Nurs Forum; 2006 Sep; 33(5):1015-21. PubMed ID: 16955128
[TBL] [Abstract][Full Text] [Related]
5. Recent advances in the hormonal treatment of breast cancer.
Boughey JC; Buzdar AU; Hunt KK
Curr Probl Surg; 2008 Jan; 45(1):13-55. PubMed ID: 18206436
[No Abstract] [Full Text] [Related]
6. The relationship between fatigue and quality of life and inflammation during anthracycline-based chemotherapy in breast cancer.
Mills PJ; Parker B; Dimsdale JE; Sadler GR; Ancoli-Israel S
Biol Psychol; 2005 Apr; 69(1):85-96. PubMed ID: 15740827
[TBL] [Abstract][Full Text] [Related]
7. [Toxicity of doxorubicin and cyclophosphamide (60 mg/600 mg/m2) in adjuvant chemotherapy for breast cancer].
Tsutani Y; Saeki T; Aogi K; Ohsumi S; Takashima S
Gan To Kagaku Ryoho; 2005 Jun; 32(6):809-13. PubMed ID: 15984521
[TBL] [Abstract][Full Text] [Related]
8. Systemic (adjuvant) treatment of primary breast cancer.
Somani N
J Assoc Physicians India; 2001 Apr; 49():451-3. PubMed ID: 11762618
[TBL] [Abstract][Full Text] [Related]
9. The association between neuropsychological impairment, self-perceived cognitive deficits, fatigue and health related quality of life in breast cancer survivors following standard adjuvant versus high-dose chemotherapy.
Mehnert A; Scherwath A; Schirmer L; Schleimer B; Petersen C; Schulz-Kindermann F; Zander AR; Koch U
Patient Educ Couns; 2007 Apr; 66(1):108-18. PubMed ID: 17320337
[TBL] [Abstract][Full Text] [Related]
10. Does cognitive impairment after chemotherapy for breast cancer improve over time or does practice make perfect?
Schagen SB; van Dam FS
J Clin Oncol; 2006 Nov; 24(32):5170-1; author reply 5171-2. PubMed ID: 17093282
[No Abstract] [Full Text] [Related]
11. [Subclinical heart damage caused by adjuvant anthracycline chemotherapy].
Dunst J
Strahlenther Onkol; 2002 Feb; 178(2):110-1. PubMed ID: 11942035
[No Abstract] [Full Text] [Related]
12. The use of aromatase inhibitors in postmenopausal women with hormone receptor positive breast cancer.
Benson JR
J Clin Oncol; 2005 Sep; 23(27):6807-9. PubMed ID: 16170197
[No Abstract] [Full Text] [Related]
13. Chemotherapy-induced nausea, vomiting, and fatigue--the role of individual differences related to sensory perception and autonomic reactivity.
Zachariae R; Paulsen K; Mehlsen M; Jensen AB; Johansson A; von der Maase H
Psychother Psychosom; 2007; 76(6):376-84. PubMed ID: 17917474
[TBL] [Abstract][Full Text] [Related]
14. Relationship between chemotherapy use and cognitive impairments in older women with breast cancer: findings from a large population-based cohort.
Du XL; Xia R; Hardy D
Am J Clin Oncol; 2010 Dec; 33(6):533-43. PubMed ID: 20023570
[TBL] [Abstract][Full Text] [Related]
15. [Feasibility of breast conservation surgery after neoadjuvant chemotherapy for breast cancer].
Zhou B; Yang DQ; Qiao XM; Tong FZ; Cao YM; Liu P; Liu HJ
Zhonghua Yi Xue Za Zhi; 2005 Mar; 85(11):769-72. PubMed ID: 15949385
[TBL] [Abstract][Full Text] [Related]
16. Fatigue, menopausal symptoms, and cognitive function in women after adjuvant chemotherapy for breast cancer: 1- and 2-year follow-up of a prospective controlled study.
Fan HG; Houédé-Tchen N; Yi QL; Chemerynsky I; Downie FP; Sabate K; Tannock IF
J Clin Oncol; 2005 Nov; 23(31):8025-32. PubMed ID: 16258100
[TBL] [Abstract][Full Text] [Related]
17. Prognostic significance of bcl-2 expression in stage III breast cancer patients who had received doxorubicin and cyclophosphamide followed by paclitaxel as adjuvant chemotherapy.
Lee KH; Im SA; Oh DY; Lee SH; Chie EK; Han W; Kim DW; Kim TY; Park IA; Noh DY; Heo DS; Ha SW; Bang YJ
BMC Cancer; 2007 Apr; 7():63. PubMed ID: 17430582
[TBL] [Abstract][Full Text] [Related]
18. Behavioral therapy intervention trial to improve sleep quality and cancer-related fatigue.
Berger AM; Kuhn BR; Farr LA; Lynch JC; Agrawal S; Chamberlain J; Von Essen SG
Psychooncology; 2009 Jun; 18(6):634-46. PubMed ID: 19090531
[TBL] [Abstract][Full Text] [Related]
19. Feasibility of concurrent adjuvant chemotherapy and radiotherapy after breast-conserving surgery in early breast cancer.
Han S; Kim J; Sohn S; Kwak GH; Kim JY; Park K
J Surg Oncol; 2007 Jan; 95(1):45-50. PubMed ID: 17192866
[TBL] [Abstract][Full Text] [Related]
20. [Adjuvant doxorubicin and cyclophosphamide followed by weekly paclitaxel for Japanese women with node-positive breast cancer: a multi-institutional feasibility study in a variety of practice settings in Kyushu].
Anan K; Mitsuyama S; Taniguchi H; Yamamoto Y; Fujiyoshi K; Tateishi T; Tamura K
Gan To Kagaku Ryoho; 2006 Oct; 33(10):1417-22. PubMed ID: 17033230
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
